- Home
- MKTW vs BRNS Comparison
MKTW vs BRNS Comparison
Compare MKTW & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- BRNS
- Stock Information
- Founded
- MKTW 1999
- BRNS 2016
- Country
- MKTW United States
- BRNS United Kingdom
- Employees
- MKTW N/A
- BRNS N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MKTW Technology
- BRNS Health Care
- Exchange
- MKTW Nasdaq
- BRNS Nasdaq
- Market Cap
- MKTW 46.9M
- BRNS 55.9M
- IPO Year
- MKTW N/A
- BRNS 2021
- Fundamental
- Price
- MKTW $14.48
- BRNS $1.37
- Analyst Decision
- MKTW Hold
- BRNS Strong Buy
- Analyst Count
- MKTW 1
- BRNS 1
- Target Price
- MKTW $20.00
- BRNS $3.00
- AVG Volume (30 Days)
- MKTW 14.1K
- BRNS 261.2K
- Earning Date
- MKTW 11-06-2025
- BRNS 11-05-2025
- Dividend Yield
- MKTW 5.52%
- BRNS N/A
- EPS Growth
- MKTW 59.71
- BRNS N/A
- EPS
- MKTW 2.83
- BRNS N/A
- Revenue
- MKTW $358,121,000.00
- BRNS $14,969,000.00
- Revenue This Year
- MKTW N/A
- BRNS N/A
- Revenue Next Year
- MKTW N/A
- BRNS N/A
- P/E Ratio
- MKTW $5.11
- BRNS N/A
- Revenue Growth
- MKTW N/A
- BRNS 1766.46
- 52 Week Low
- MKTW $9.08
- BRNS $0.64
- 52 Week High
- MKTW $21.74
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- MKTW 39.32
- BRNS 52.10
- Support Level
- MKTW $13.50
- BRNS $1.26
- Resistance Level
- MKTW $14.91
- BRNS $1.41
- Average True Range (ATR)
- MKTW 0.57
- BRNS 0.18
- MACD
- MKTW -0.01
- BRNS -0.01
- Stochastic Oscillator
- MKTW 43.35
- BRNS 39.10
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.